Insights On Outsourced Drug Development

31. Step-By-Step Guide To Tech Transfer Preparation And Execution 10/31/2024

    How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?

32. Early Development Considerations For Late-Stage NCE Success – Part Two 1/18/2024

    Discover how strategic partnerships, robust process development, and a keen awareness of supply chain vulnerabilities can pave the way to a successful clinical trial.

33. New And Upcoming Trends In Immunodiagnostics 7/15/2024

    Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.

34. Human Skin Explant Model For The Investigation Of Topical Therapeutics 8/4/2025

    Learn more about an ex vivo cultured human skin explant model in which pathological tissue integrity, barrier function, and metabolic stability have been characterized over time.

35. Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration 8/20/2025

    Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.

36. Merck Process Transfer And Scale-Up Of Batch Protein A 6/30/2025

    Explore cost-saving innovations in purification using a system that achieves consistent product quality and yield while significantly reducing resin use and enhancing large-scale efficiency.

37. Ophthalmic Drug Delivery 4/11/2024

    Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

38. Improved Cell Viability For Multi-Day Cell-Based Assays 7/24/2025

    Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.

39. Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics 12/12/2024

    Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.

40. A Solvent-Free, Fusion-Based ASD Manufacturing Process 3/5/2024

    Explore a solvent-free alternative for the production of amorphous solid dispersions (ASDs) that not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.